Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (international nonproprietary name meloxicam) in patients with pyrophosphate arthropathy (PA). One-month Amelotex® therapy is shown to have a good clinical effect in patients wit...
Main Authors: | Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-09-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/367 |
Similar Items
-
Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01) -
MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01) -
Experience with methotrexate in a patient with calcium pyrophosphate crystal deposition disease
by: E. V. Ilyinykh, et al.
Published: (2019-10-01) -
Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01) -
Rasshifrovka diagnoza s pomoshch'yupolyarizatsionnoy mikroskopii posle 12 let sushchestvovaniya artrita(opisanie sluchaya)
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2011-12-01)